Cargando…
Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment
Gene therapies (GTs) are considered to be a paradigm-shifting class of treatments with the potential to treat previously incurable diseases or those with significant unmet treatment needs. However, considerable challenges remain in their health technology assessment (HTA), mainly stemming from the i...
Autores principales: | Qiu, Tingting, Pochopien, Michal, Liang, Shuyao, Saal, Gauri, Paterak, Ewelina, Janik, Justyna, Toumi, Mondher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863657/ https://www.ncbi.nlm.nih.gov/pubmed/35223725 http://dx.doi.org/10.3389/fpubh.2022.773629 |
Ejemplares similares
-
The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMs
por: Polek, Hubert, et al.
Publicado: (2023) -
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
por: Pochopień, Michał, et al.
Publicado: (2021) -
Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers
por: Qiu, Tingting, et al.
Publicado: (2021) -
Key Considerations for an Economic and Legal Framework Facilitating Medical Travel
por: Hinrichs-Krapels, Saba, et al.
Publicado: (2016) -
Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
por: Pochopien, Michal, et al.
Publicado: (2019)